Image

PMS of Spesolimab I.V. in GPP Patients With Acute Symptoms

Not Recruiting
18 years of age
Both
Phase N/A
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

Non-interventional cohort study in patients with newly initiated Spesolimab to evaluate the incidence of adverse drug reactions and to understand generalized pustular psoriasis (GPP) disease activities in the real world setting.

Eligibility

Inclusion Criteria:

  • GPP patients with acute symptoms who are administered Spesolimab Intravenous (I.V.) Infusion in Japan
  • Patients who have never been treated with Spesolimab I.V. Infusion before enrolment

Exclusion Criteria:

  • None

Study details

Generalized Pustular Psoriasis

NCT05670821

Boehringer Ingelheim

21 March 2025

Contact a study center

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.